Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.

Identifieur interne : 001962 ( Ncbi/Merge ); précédent : 001961; suivant : 001963

Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.

Auteurs : Shuo Shen [Singapour] ; Timothy H P. Tan ; Yee-Joo Tan

Source :

RBID : pubmed:17502675

Descripteurs français

English descriptors

Abstract

The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. To study the maturation pathway of the S glycoprotein of the severe acute respiratory syndrome (SARS)-coronavirus (CoV) within the host cell, a T7/vaccinia virus-based expression system coupled to immunoprecipitation with anti-S antibodies was used to test and analyze different forms of the S glycoprotein. The state of maturity of the S glycoprotein can be deduced from its sensitivity to hydrolysis by endoglycosidase H (EndoH) or N-glycosidase F (N-Gly F). A fully matured S glycoprotein will be modified with complex oligosaccharides which makes it resistant to cleavage by EndoH but not by N-Gly F. By exploiting this characteristic, it is then possible to determine which forms of the immunoprecipitated S protein are properly processed by the host cell. With this system, many different constructs of the S glycoprotein can be analyzed in parallel thus providing another method by which to study the functional domains of S involved in membrane fusion event that occurs during viral infection.

DOI: 10.1007/978-1-59745-393-6_9
PubMed: 17502675

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:17502675

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.</title>
<author>
<name sortKey="Shen, Shuo" sort="Shen, Shuo" uniqKey="Shen S" first="Shuo" last="Shen">Shuo Shen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Collaborative Antiviral Research Group, Institute of Molecular and Cell Biology, Proteos, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Collaborative Antiviral Research Group, Institute of Molecular and Cell Biology, Proteos</wicri:regionArea>
<wicri:noRegion>Proteos</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tan, Timothy H P" sort="Tan, Timothy H P" uniqKey="Tan T" first="Timothy H P" last="Tan">Timothy H P. Tan</name>
</author>
<author>
<name sortKey="Tan, Yee Joo" sort="Tan, Yee Joo" uniqKey="Tan Y" first="Yee-Joo" last="Tan">Yee-Joo Tan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17502675</idno>
<idno type="pmid">17502675</idno>
<idno type="doi">10.1007/978-1-59745-393-6_9</idno>
<idno type="wicri:Area/PubMed/Corpus">001E16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E16</idno>
<idno type="wicri:Area/PubMed/Curation">001E16</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E16</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001E11</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E11</idno>
<idno type="wicri:Area/Ncbi/Merge">001962</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.</title>
<author>
<name sortKey="Shen, Shuo" sort="Shen, Shuo" uniqKey="Shen S" first="Shuo" last="Shen">Shuo Shen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Collaborative Antiviral Research Group, Institute of Molecular and Cell Biology, Proteos, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Collaborative Antiviral Research Group, Institute of Molecular and Cell Biology, Proteos</wicri:regionArea>
<wicri:noRegion>Proteos</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tan, Timothy H P" sort="Tan, Timothy H P" uniqKey="Tan T" first="Timothy H P" last="Tan">Timothy H P. Tan</name>
</author>
<author>
<name sortKey="Tan, Yee Joo" sort="Tan, Yee Joo" uniqKey="Tan Y" first="Yee-Joo" last="Tan">Yee-Joo Tan</name>
</author>
</analytic>
<series>
<title level="j">Methods in molecular biology (Clifton, N.J.)</title>
<idno type="ISSN">1064-3745</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>COS Cells</term>
<term>Chlorocebus aethiops</term>
<term>Gene Expression</term>
<term>Glycosylation</term>
<term>Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase (chemistry)</term>
<term>Membrane Glycoproteins (analysis)</term>
<term>Membrane Glycoproteins (biosynthesis)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase (chemistry)</term>
<term>Protein Modification, Translational (physiology)</term>
<term>Recombinant Proteins (analysis)</term>
<term>Recombinant Proteins (biosynthesis)</term>
<term>Recombinant Proteins (genetics)</term>
<term>SARS Virus (genetics)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vaccinia virus (genetics)</term>
<term>Vero Cells</term>
<term>Viral Envelope Proteins (analysis)</term>
<term>Viral Envelope Proteins (biosynthesis)</term>
<term>Viral Envelope Proteins (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules COS</term>
<term>Cellules Vero</term>
<term>Expression des gènes</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (analyse)</term>
<term>Glycoprotéines membranaires (biosynthèse)</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycosylation</term>
<term>Mannosyl-glycoprotéine-endo-bêta-N-acétylgluco saminidase ()</term>
<term>Modification traductionnelle des protéines (physiologie)</term>
<term>Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase ()</term>
<term>Protéines de l'enveloppe virale (analyse)</term>
<term>Protéines de l'enveloppe virale (biosynthèse)</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines recombinantes (analyse)</term>
<term>Protéines recombinantes (biosynthèse)</term>
<term>Protéines recombinantes (génétique)</term>
<term>Virus de la vaccine (génétique)</term>
<term>Virus du SRAS (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase</term>
<term>Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>SARS Virus</term>
<term>Vaccinia virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
<term>Virus de la vaccine</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Modification traductionnelle des protéines</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Protein Modification, Translational</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>COS Cells</term>
<term>Chlorocebus aethiops</term>
<term>Gene Expression</term>
<term>Glycosylation</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules COS</term>
<term>Cellules Vero</term>
<term>Expression des gènes</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycosylation</term>
<term>Mannosyl-glycoprotéine-endo-bêta-N-acétylgluco saminidase</term>
<term>Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. To study the maturation pathway of the S glycoprotein of the severe acute respiratory syndrome (SARS)-coronavirus (CoV) within the host cell, a T7/vaccinia virus-based expression system coupled to immunoprecipitation with anti-S antibodies was used to test and analyze different forms of the S glycoprotein. The state of maturity of the S glycoprotein can be deduced from its sensitivity to hydrolysis by endoglycosidase H (EndoH) or N-glycosidase F (N-Gly F). A fully matured S glycoprotein will be modified with complex oligosaccharides which makes it resistant to cleavage by EndoH but not by N-Gly F. By exploiting this characteristic, it is then possible to determine which forms of the immunoprecipitated S protein are properly processed by the host cell. With this system, many different constructs of the S glycoprotein can be analyzed in parallel thus providing another method by which to study the functional domains of S involved in membrane fusion event that occurs during viral infection.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17502675</PMID>
<DateCompleted>
<Year>2007</Year>
<Month>06</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">1064-3745</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>379</Volume>
<PubDate>
<Year>2007</Year>
</PubDate>
</JournalIssue>
<Title>Methods in molecular biology (Clifton, N.J.)</Title>
<ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.</ArticleTitle>
<Pagination>
<MedlinePgn>127-35</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. To study the maturation pathway of the S glycoprotein of the severe acute respiratory syndrome (SARS)-coronavirus (CoV) within the host cell, a T7/vaccinia virus-based expression system coupled to immunoprecipitation with anti-S antibodies was used to test and analyze different forms of the S glycoprotein. The state of maturity of the S glycoprotein can be deduced from its sensitivity to hydrolysis by endoglycosidase H (EndoH) or N-glycosidase F (N-Gly F). A fully matured S glycoprotein will be modified with complex oligosaccharides which makes it resistant to cleavage by EndoH but not by N-Gly F. By exploiting this characteristic, it is then possible to determine which forms of the immunoprecipitated S protein are properly processed by the host cell. With this system, many different constructs of the S glycoprotein can be analyzed in parallel thus providing another method by which to study the functional domains of S involved in membrane fusion event that occurs during viral infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shen</LastName>
<ForeName>Shuo</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Collaborative Antiviral Research Group, Institute of Molecular and Cell Biology, Proteos, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Timothy H P</ForeName>
<Initials>TH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Yee-Joo</ForeName>
<Initials>YJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Methods Mol Biol</MedlineTA>
<NlmUniqueID>9214969</NlmUniqueID>
<ISSNLinking>1064-3745</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.96</RegistryNumber>
<NameOfSubstance UI="D017038">Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.1.52</RegistryNumber>
<NameOfSubstance UI="D043524">Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017038" MajorTopicYN="N">Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D043524" MajorTopicYN="N">Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046188" MajorTopicYN="N">Protein Modification, Translational</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="Y">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014616" MajorTopicYN="N">Vaccinia virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>7</NumberOfReferences>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>5</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>5</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17502675</ArticleId>
<ArticleId IdType="pii">1-59745-393-5:127</ArticleId>
<ArticleId IdType="doi">10.1007/978-1-59745-393-6_9</ArticleId>
<ArticleId IdType="pmc">PMC7120769</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1779-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781537</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Jan;80(2):941-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16378996</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2004 Sep 1;326(2):288-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15302214</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2005 Mar;79(6):3289-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15731223</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1994 Sep;68(9):5772-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8057459</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16116101</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Cell Biol. 1997 Nov 3;139(3):613-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9348279</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Singapour</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Tan, Timothy H P" sort="Tan, Timothy H P" uniqKey="Tan T" first="Timothy H P" last="Tan">Timothy H P. Tan</name>
<name sortKey="Tan, Yee Joo" sort="Tan, Yee Joo" uniqKey="Tan Y" first="Yee-Joo" last="Tan">Yee-Joo Tan</name>
</noCountry>
<country name="Singapour">
<noRegion>
<name sortKey="Shen, Shuo" sort="Shen, Shuo" uniqKey="Shen S" first="Shuo" last="Shen">Shuo Shen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001962 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001962 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:17502675
   |texte=   Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:17502675" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021